[go: up one dir, main page]

Follow
John E Burke
John E Burke
Professor of Biochemistry and Microbiology, University of Victoria
Verified email at uvic.ca - Homepage
Title
Cited by
Cited by
Year
Accurate prediction of protein structures and interactions using a three-track neural network
M Baek, F DiMaio, I Anishchenko, J Dauparas, S Ovchinnikov, GR Lee, ...
Science 373 (6557), 871-876, 2021
59162021
Phospholipase A2 structure/function, mechanism, and signaling1
JE Burke, EA Dennis
Journal of lipid research 50, S237-S242, 2009
11942009
Recommendations for performing, interpreting and reporting hydrogen deuterium exchange mass spectrometry (HDX-MS) experiments
GR Masson, JE Burke, NG Ahn, GS Anand, C Borchers, S Brier, ...
Nature methods 16 (7), 595-602, 2019
7552019
Phospholipase A2 Biochemistry
JE Burke, EA Dennis
Cardiovascular drugs and therapy 23 (1), 49-59, 2009
5912009
Structural basis for activation and inhibition of class I phosphoinositide 3-kinases
O Vadas, JE Burke, X Zhang, A Berndt, RL Williams
Science signaling 4 (195), re2-re2, 2011
3482011
Oncogenic mutations mimic and enhance dynamic events in the natural activation of phosphoinositide 3-kinase p110α (PIK3CA)
JE Burke, O Perisic, GR Masson, O Vadas, RL Williams
Proceedings of the National Academy of Sciences, 2012
3302012
Structural basis for regulation of phosphoinositide kinases and their involvement in human disease
JE Burke
Molecular cell 71 (5), 653-673, 2018
2842018
Structure and flexibility of the endosomal Vps34 complex reveals the basis of its function on membranes
K Rostislavleva, N Soler, Y Ohashi, L Zhang, E Pardon, JE Burke, ...
Science 350 (6257), aac7365, 2015
2842015
Diversity-oriented synthesis yields novel multistage antimalarial inhibitors
N Kato, E Comer, T Sakata-Kato, A Sharma, M Sharma, M Maetani, ...
Nature 538 (7625), 344-349, 2016
2832016
Synergy in activating class I PI3Ks
JE Burke, RL Williams
Trends in biochemical sciences 40 (2), 88-100, 2015
2382015
Novel roles of phosphoinositides in signaling, lipid transport, and disease
GRV Hammond, JE Burke
Current Opinion in Cell Biology 63, 57-67, 2020
2302020
An overview of hydrogen deuterium exchange mass spectrometry (HDX-MS) in drug discovery
GR Masson, ML Jenkins, JE Burke
Expert opinion on drug discovery 12 (10), 981-994, 2017
2002017
G protein–coupled receptor–mediated activation of p110β by Gβγ is required for cellular transformation and invasiveness
HA Dbouk, O Vadas, A Shymanets, JE Burke, RS Salamon, BD Khalil, ...
Science signaling 5 (253), ra89-ra89, 2012
1832012
Vesicular and non-vesicular transport feed distinct glycosylation pathways in the Golgi
G D’Angelo, T Uemura, CC Chuang, E Polishchuk, M Santoro, ...
Nature 501 (7465), 116-120, 2013
1792013
Molecular basis of Lys11-polyubiquitin specificity in the deubiquitinase Cezanne
TET Mevissen, Y Kulathu, MPC Mulder, PP Geurink, SL Maslen, M Gersch, ...
Nature 538 (7625), 402-405, 2016
1772016
Structures of PI4KIIIβ complexes show simultaneous recruitment of Rab11 and its effectors
JE Burke, AJ Inglis, O Perisic, GR Masson, SH McLaughlin, F Rutaganira, ...
Science 344 (6187), 1035-1038, 2014
1662014
Molecular determinants of PI3Kγ-mediated activation downstream of G-protein–coupled receptors (GPCRs)
O Vadas, HA Dbouk, A Shymanets, O Perisic, JE Burke, WF Abi Saab, ...
Proceedings of the National Academy of Sciences 110 (47), 18862-18867, 2013
1642013
Beyond PI3Ks: targeting phosphoinositide kinases in disease
JE Burke, J Triscott, BM Emerling, GRV Hammond
Nature Reviews Drug Discovery 22 (5), 357-386, 2023
1332023
Ras binder induces a modified switch-II pocket in GTP and GDP states
DR Gentile, MK Rathinaswamy, ML Jenkins, SM Moss, BD Siempelkamp, ...
Cell chemical biology 24 (12), 1455-1466. e14, 2017
1332017
Class I phosphoinositide 3-kinase (PI3K) regulatory subunits and their roles in signaling and disease
MK Rathinaswamy, JE Burke
Advances in Biological Regulation 75, 100657, 2020
1282020
The system can't perform the operation now. Try again later.
Articles 1–20